antiangiogenesis gene therapy (EntreMed/Cell Genesys)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameantiangiogenesis gene therapy (EntreMed/Cell Genesys)

Drug Alias NameAAV gene therapy (EntreMed/Cell Genesys)Endostatin/Angiostatin gene therapy (EntreMed/Cell Genesys)cancer therapy (EntreMed/Cell Genesys)adenoviral gene therapy (EntreMed/Cell Genesys)

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionAngiogenesis inhibitors

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCasi Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiosante Pharmaceuticals Inc Casi Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A